Five-Year Survival of Alpha-Fetoprotein-Producing Gastric Cancer with Synchronous Liver Metastasis: A Case Report |
Koneri, Kenji
(Department of Gastroenterological Surgery, University of Fukui)
Hirono, Yasuo (Department of Gastroenterological Surgery, University of Fukui) Fujimoto, Daisuke (Department of Gastroenterological Surgery, University of Fukui) Sawai, Katsuji (Department of Gastroenterological Surgery, University of Fukui) Morikawa, Mitsuhiro (Department of Gastroenterological Surgery, University of Fukui) Murakami, Makoto (Department of Gastroenterological Surgery, University of Fukui) Goi, Takanori (Department of Gastroenterological Surgery, University of Fukui) Iida, Atsushi (Department of Gastroenterological Surgery, University of Fukui) Katayama, Kanji (Cancer Care Promotion Center, University of Fukui) Yamaguchi, Akio (Department of Gastroenterological Surgery, University of Fukui) |
1 | Adachi Y, Tsuchihashi J, Shiraishi N, Yasuda K, Etoh T, Kitano S. AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients. Oncology 2003;65:95-101. DOI ScienceOn |
2 | Kochi M, Fujii M, Kaiga T, Takahashi T, Morishita Y, Kobayashi M, et al. FLEP chemotherapy for alpha-fetoproteinproducing gastric cancer. Oncology 2004;66:445-449. DOI ScienceOn |
3 | Inoue M, Sano T, Kuchiba A, Taniguchi H, Fukagawa T, Katai H. Long-term results of gastrectomy for alpha-fetoproteinproducing gastric cancer. Br J Surg 2010;97:1056-1061. DOI ScienceOn |
4 | Asami T, Kokawa A, Sugimori K, Tomita N, Shirato K, Morimoto M, et al. A case of AFP-producing gastric cancer with multiple liver metastases responding to CPT-11 and cisplatin combination chemotherapy. Gan To Kagaku Ryoho 2002;29:1985- 1988. |
5 | Yoshioka M, Inoue N, Someda H, Noguchi M, Sawada M, Azuma K, et al. A case of AFP-producing gastric cancer resected after efficient S-1/CDDP combination chemotherapy. Gan To Kagaku Ryoho 2011;38:105-108. |
6 | Sakurai N, Yamauchi J, Fukushima N, Shibuma H, Ikeda E, Sasou S. A case of non-recurred long-term survival after chemotherapy for liver metastasis of AFP-producing gastric carcinoma. Jpn J Gastroenterol Surg 2005;38:418-423. DOI |
7 | Nagahama T, Maruyama M, Toukairin Y, Baba H, Yoshida T, Kure N, et al. Hepatic arterial injection therapy (HAI) for metastatic liver tumor from gastric cancer. Gan To Kagaku Ryoho 2000;27:1920-1923. |
8 | Takada J, Kenno S, Aoki T, Hamada H, Katsuki Y. A case in which intra-arterial chemotherapy for simultaneous hepatic metastases markedly improved AFP-producing gastric cancer. Gan To Kagaku Ryoho 2009;36:2326-2329. |
9 | Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al; SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-390. DOI ScienceOn |
10 | Kim C, Lee JL, Choi YH, Kang BW, Ryu MH, Chang HM, et al. Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer. Invest New Drugs 2012;30:306-315. DOI |
11 | Amemiya H, Kono K, Mori Y, Takahashi A, Ichihara F, Iizuka H, et al. High frequency of c-Met expression in gastric cancers producing alpha- fetoprotein. Oncology 2000;59:145-151. DOI ScienceOn |
12 | Gao JJ, Inagaki Y, Xue X, Qu XJ, Tang W. c-Met: a potential therapeutic target for hepatocellular carcinoma. Drug Discov Ther 2011;5:2-11. DOI |
13 | Chun H, Kwon SJ. Clinicopathological characteristics of alpha-fetoprotein-producing gastric cancer. J Gastric Cancer 2011;11:23-30. DOI ScienceOn |
14 | Kono K, Amemiya H, Sekikawa T, Iizuka H, Takahashi A, Fujii H, et al. Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg 2002;19:359-365. DOI ScienceOn |
15 | Ishigami S, Natsugoe S, Nakashima H, Tokuda K, Nakajo A, Okumura H, et al. Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer. Hepatogastroenterology 2006;53:338-341. |
![]() |